Congenital misalignment of pulmonary vessels (MPV) with alveolar capillary dysplasia is a rare condition consisting of anomalous veins in bronchovascular bundles, a decreased number of alveolar capillaries, and increased muscularization of pulmonary arterioles. In the literature, infants reported as having such a malformation developed respiratory distress with persistent pulmonary hypertension and ultimately died. We report the case of an infant with MPV and alveolar capillary dysplasia who was unresponsive to maximal cardiorespiratory support, including high-frequency oscillatory ventilation and inhaled nitric oxide; the infant died of pulmonary hemorrhage after 19 days, during venoarterial extracorporeal membrane oxygenation bypass. We conclude that the diagnosis of MPV and alveolar capillary dysplasia should be considered during autopsy of infants who have died of irreversible persistent pulmonary hypertension. If a lung biopsy in infants with prolonged refractory hypoxemia confirms such diagnosis before death, expensive and invasive treatments such as extracorporeal membrane oxygenation could be avoided.
Congenital misalignment of pulmonary vessels (MPV) with alveolar capillary dysplasia is a rare disorder of pulmonary vascular development associated with persistent pulmonary hypertension (PPHN) and unremitting hypoxemia. It was first described in 1981 in a full-term infant girl who developed respiratory distress and PPHN at birth and died of hypoxemia after 40 hours. At autopsy, a decreased number of alveolar capillaries, increased muscularization of pulmonary arterioles, and anomalous veins in bronchovascular bundles were detected. In the literature, 22 cases have been described with this condition. All infants developed respiratory distress with PPHN within the first 2 days of life. Despite a transient response to maximal supportive therapies, all patients died. [1] [2] [3] [4] [5] [6] 
CASE REPORT
This newborn infant girl was born at 41 weeks' gestation by cesarean section; the pregnancy was uncomplicated, birth weight was 2790 gm, and Apgar scores were 7 and 9 at 1 and 5 minutes, respectively. At 3 hours of age, a cyanotic spell occurred and ambient oxygen concentration increased. Next, respiratory status deteriorated and respiratory distress occurred; the infant was intubated at 20 hours, and mechanical ventilation was started. Fractional inspired oxygen (FIO 2 ) and ventilatory settings were progressively increased; at FIO 2 of 100%, arterial blood gas showed a pH of 7.24, PCO 2 of 41 mm Hg, PO 2 of 26 mm Hg, HCO 3 of 21, and base excess of Ϫ4. The chest radiograph showed well-aerated lungs and nonspecific diffuse haziness. Echocardiography showed an anatomically normal heart with a right to left shunt through a patent ductus arteriosus and a small foramen ovale. An infection screen was performed, and ampicillin and gentamicin were administered. Inotropic support with dopamine and dobutamine was started to maintain normal blood pressure values. The baby continued to be hypoxemic despite high ventilatory settings; at 26 hours, high-frequency oscillatory ventilation and nitric oxide at 20 parts per million were started. Little improvement in oxygenation and in her general condition were observed over the next 48 hours, but echocardiography continued to show signs of PPHN. A subsequent hypoxemia developed and up to 40 parts per million of nitric oxide were necessary to maintain PAO 2 of Ͼ40 mm Hg; after 5 days, the infant was transferred to our center for extracorporeal membrane oxygenation (ECMO). After admission, high-frequency oscillatory ventilation was continued with 10 Hz, FIO 2 of 100%, amplitude at 40 cm H 2 O, mean airway pressure at 17 cm H 2 O; pH was 7.40, PaCO 2 was 38 torr, PaO 2 was 35 torr, HCO 3 was 24, SaO 2 was at 68%, and the oxygenation index was at 48. Venoarterial ECMO was started, with cannulation of the right internal jugular vein and right common carotid artery, and ventilatory settings were reduced to keep the lungs at rest; an extracorporeal blood flow of 80 ml/kg per minute was required to maintain good PaO 2 values. Repeated attempts to wean the infant from extracorporeal support over the next 2 weeks were unsuccessful. The infant died of pulmonary hemorrhage on the day 19, after 14 days of ECMO support.
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Pathologic Findings
At autopsy, the infant was found to be the appropriate size for her age, without developmental anomalies. The heart was anatomically normal and hypertrophy of the right ventricle was present. Both lungs were voluminous, reddish, and of increased consistency.
Histopathologic Features of the Lungs
Microscopic examination of the lungs showed a malposition of pulmonary veins; the veins were adjacent to pulmonary artery branches rather than in their normal position in the interlobular septa. In addition, increased muscularization of pulmonary arteries was found (Figures 1 and 2) . Maldevelopment of the pulmonary lobules with simple and rounded air spaces, lined with cuboidal epithelial cells, was observed. Interlobular septa were broad and contained rare dilated thin-walled vascular spaces and rare capillaries (Figure 3 ). The capillaries did not make contact with alveolar epithelium; therefore, the blood-gas barrier was not formed normally. Additional findings were hypertrophy with progressive fibrous vascular occlusion of muscular pulmonary arteries and elastosis of the elastic laminae. (Figure 1 ). Diffuse intrapulmonary hemorrhage with intra-alveolar and intrabronchiolar hemosiderin-containing macrophages were seen. (Figure 4) . Sections of the lung displayed interstitial chronic inflammatory infiltrate and intra-alveolar acute exudate.
DISCUSSION
MPV with alveolar capillary dysplasia is characterized pathologically by a lack of formation and ingrowth of alveolar capillaries that do not make contact with alveolar epithelium, by medial muscular thickening of pulmonary artery branches with muscularization of intraacinar arteries, by thickened alveolar walls, and by anomalously situated pulmonary veins running along pulmonary arteries and sharing the same adventitial sheath. 4, 7 Features may also include a reduced number of alveoli and patchy distribution of histopathologic changes. Failure of formation and ingrowth of alveolar capillaries leads to the absence of a normal air-blood barrier. Moreover, there are fewer capillaries and arterioles; the reduction in capillary surface area could lead to increased pulmonary vascular resistance, pulmonary hypertension, and increased muscularization.
All reported infants showed the onset of respiratory failure and PPHN within the first 2 days of life and progression of the disease in the following days or weeks. The severity of illness was different between infants, and a transitory response to maximal supportive treatments, including high-frequency oscillatory ventilation, inhaled nitric oxide, or ECMO, was described. 5, 7, 8 However, all reported infants died; this is not surprising considering that the underlying pathophysiology is an irreversible structural defect. Age of death varied from 2 to 61 days. 7, 9 Sex distribution of MPV and alveolar capillary dysplasia is similar. Most occurrences are sporadic; however, a familial predisposition has been described in two cases. 1, 10 Accompanying anomalies involving the genitourinary tract and the gastrointestinal or cardiac systems are frequent. The incidence of the disease is not known, although it is probably present more often than it is recognized; infants with MPV may have been diagnosed having a so-called "idiopathic" PPHN. In fact, the clinical features of MPV are similar to those of PPHN, with acute respiratory failure and persistent right to left shunt through fetal channels causing severe hypoxemia. Other rare diseases, such as surfactant protein B deficiency, could present in a similar fashion.
A triad consisting of an association of congenital malformations, a honeymoon period, and subsequent unremitting hypoxemia, has been proposed to alert neonatal clinicians to MPV. 6 The diagnosis of MPV requires a careful pathologic examination at autopsy or biopsy. It is of considerable importance to obtain autopsies on all patients who have died of refractory hypoxemia with PPHN, because some of these may have MPV as a cause of pulmonary hypertension. Recognizing this condition will aid in parental counseling and provide better understanding of this disease. If a rapid premortem diagnosis is made, early recognition of this condition could allow us to establish a more appropriate management. We think a lung biopsy should be considered in term infants with refractory hypoxemia when no improvement of lung function is seen after 8 to 10 days of maximal cardiopulmonary support. Considering the progression of the disease, with ultimate death in all known infants with MPV and alveolar capillary dysplasia, an option could be lung or lung/heart transplantation. If such an option is not available, early introduction of compassionate management could be considered, avoiding costly and invasive treatments such as ECMO. A malpositioned pulmonary vein (V) is seen next to a pulmonary artery branch (A). B, bronchus. This figure is a hematoxylin-eosin stain; original magnification is 2.5 ϫ 10.
